跳至主要内容
临床试验/NCT01893489
NCT01893489已完成1 期

Phase I Study to Evaluated the Safety of Noninvasive Molecular Imaging for the Detection of Inflammation in Carotid Atherosclerotic Lesions by Using Ga-68-NOTA-MSA in Healthy Volunteers and Patients With Coronary Artery Disease

Korea University2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
side reactions at MSA injection site of the skin

研究概览

简要总结

Until now, no specific atherosclerosis-targeting agent labeled with positron emitter is not yet available. Investigators developed neomannosyl human serum albumin(MSA) for the terminal mannose residues of MSA binding with the mannose receptors of macrophages in atherosclerosis, and investigators investigate whether 68Ga-MSA can be a novel agent for non-invasive molecular imaging of carotid atherosclerotic lesion in PET.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
是

入选标准

  • ••coronary artery disease patients with carotid plaques
  • •control without carotid plaque

排除标准

  • ••pregnancy, allergy to albumin, any acute or chronic inflammatory disease, hematologic disease, liver disease, renal disease

研究组 & 干预措施

Atherosclerosis

Active Comparator

coronary artery disease patients with carotid plaques confirmed by a ultrasound study

干预措施: 68Gallium-MSA (Other)

control

Sham Comparator

no coronary artery disease patients without carotid plaques confirmed by a ultrasound study

干预措施: 68Gallium-MSA (Other)

结局指标

主要结局

side reactions at MSA injection site of the skin

时间窗: with 2 hours after MSA injection

development of unexpected skin rashes or other skin lesions at MSA injection site of the skin with 2 hours after MSA injection

unstable changes of vital signs and development of abnormal biochemical parameters

时间窗: 24 hours after MSA injection

This includes unstable changes of vital signs including blood pressure, body temperature and heart rate, and abnormal changes of biochemical parameters such as hematologic, hepatic and renal functions.

次要结局

  • standard uptake unit(SUV) at carotid arteries(baseline)
  • SUV at aorta and iliac arteries(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Seog Seo

Professor of Medicine

Korea University

研究点 (2)

Loading locations...

相似试验

招募中
1 期
PedMAb1HIV/AIDS
PACTR202205715278722South African Medical Research Council72
进行中(未招募)
1 期
Evaluation study of tolerance and efficacy of a treatment with radium-223 in patients with clear cell renal cell carcinoma with bone metastases.Renal cell carcinoma patients with bone metastases, with or without visceral metastases.
EUCTR2014-003774-16-FRA.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie )
招募中
2 期
MB-CART19.1 r/r CD19+ BCMRelapsed or refractory CD19 positive B cell malignancies (pediatric acute lymphatic leukemia [ALL], aggressive NHL)Relapsed or refractory CD19 positive B cell malignancies (adult ALL, adult NHL/chronic lymphatic leukemia [CLL])Refractory/relapsed B-NHL
2024-513334-38-00Miltenyi Biomedicine GmbH49
已完成
不适用
A Phase 1 Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of the Selective Met Inhibitor, JNJ 38877605 in Subjects With Advanced or Refractory Solid Tumors.Advanced or Refractory Solid Tumorsavailable therapiesno longer likely to benefit from approved10027655
NL-OMON31546Johnson & Johnson Pharmaceutical33
招募中
1 期
A phase I safety, dose finding and feasibility trial of GD2IL18CART in patients with relapsed or refractory GD2 positive solid cancersC41Malignant neoplasm of breastMedulla of adrenal glandC50C74.1C40Malignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sites
DRKS00024109niversität Münster178
Visualization of Carotid Atherosclerosis by 68Ga-MSA | 临床试验